cetuximab,encorafenib
eli lilly,pfizer
[]
delighted to present our ttd confidence study in #gi23 about efficacy and safety in rw setting of encorafenib/cetuximab in braf mutant metastatic colorectal cancer 
Medical Oncologist at Complexo Universitario de Ourense , Gastrointestinal Malignancies @SEOM @GrupoTTD